CELLPHIRE
Cellphire has developed a proprietary method for the stabilization of blood in the dry state Current efforts and product development are aimed toward stabilized platelets for advanced wound care, transfusion, and reagent products for clinical and research diagnostics. We have been able to stabilize and modify platelets into a hemostatic agent that can be stored well beyond the current limit of 5 days. Platelets cannot be stockpiled and shortages occur because of this extremely short shelf ... life. These shortages can interrupt the treatment of cancer patients and actively bleeding surgical or trauma patients. The fragility of the national supply of platelets is a topic of discussion of several task forces and agencies planning the nation's response to a pandemic such as avian influenza. This and other natural or manmade disasters would interrupt or exceed the available supply of platelets that is needed to maintain an adequate supply or treat bleeding casualties.
CELLPHIRE
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2005-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.cellphire.com
Total Employee:
11+
Status:
Active
Contact:
2402681145
Email Addresses:
[email protected]
Total Funding:
16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Global Site Tag Euro Cloudflare JS CDN JS
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Current Advisors List
Current Employees Featured
Founder
Investors List
Simcah Management
Simcah Management investment in Series A - CellPhire
Maryland Venture Fund
Maryland Venture Fund investment in Debt Financing - CellPhire
Official Site Inspections
http://www.cellphire.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.79 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "CellPhire"
About Us - Cellphire
CellPhire - Crunchbase Company Profile & Funding
Cellphire has developed a proprietary method for the stabilization of blood in the dry state. Current efforts and product development are aimed toward stabilized platelets for advanced wound care, transfusion, and reagent products for …See details»
Cellphire Therapeutics, Inc. | LinkedIn
Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to ...See details»
Leadership Bios - Cellphire
He joined Cellphire in 2006 and has led the development of the company’s first line of hemostatic products. Prior to joining Cellphire, Dr. Fitzpatrick served as Chief Operating Officer of …See details»
Cellphire - Overview, News & Similar companies | ZoomInfo.com
May 27, 2021 Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial ROCKVILLE, Md., March 29, 2022 /PRNewswire/ -- Cellphire Therapeutics, Inc., …See details»
CellPhire Therapeutics Company Profile 2024: Valuation, Funding ...
CellPhire Therapeutics was founded in 2005. Where is CellPhire Therapeutics headquartered? CellPhire Therapeutics is headquartered in Rockville, MD. What is the size of CellPhire …See details»
CellPhire - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... obfuscated — Apr 2, 2021: Series A - CellPhire . 1: …See details»
Cellphire Therapeutics - Craft
Cellphire Therapeutics is a biotechnology company focusing on cell stabilization technology. It develops freeze-dried platelet-derived hemostatic agents, cryopreserved platelets, and other …See details»
CellPhire - Contacts, Employees, Board Members, Advisors & Alumni
Organization. CellPhire . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. CellPhire has 5 current employee profiles, …See details»
Cellphire Therapeutics, Inc. Closes $15 Million ... - Markets Insider
ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million …See details»
Cellphire
Apr 5, 2021 “Cellphire has grown significantly over the past 16 years, and it is time to reflect that growth and our success in our brand identity,” said Rafael Jorda, Interim CEO, Cellphire …See details»
Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding …
ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million …See details»
CellPhire - Updates, News, Events, Signals & Triggers - Crunchbase
CellPhire may be growing as it is listed among key players in the choroidal neovascularization drug market, which suggests recognition in its field. The company is also mentioned in the …See details»
Cellphire Therapeutics, Inc. Closes $15 Million Series A ... - Benzinga
ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million …See details»
Cellphire Therapeutics Names Michael Gaffney as Company's New …
Apr 20, 2021 Cellphire Therapeutics, Inc. is a biotechnology company developing next-generation platelet-based therapeutics. The company is applying its proprietary cell …See details»
Cellphire
Cellphire Therapeutics, Inc. is a biotechnology company developing next-generation platelet-based therapeutics. The company is applying its proprietary cell stabilization technology to …See details»
The future of healthcare and why I’m now leading Cellphire
Jun 15, 2021 Cellphire is exploring other uses for its treatments, including to deliver drugs and help patients taking anticoagulants. Loaded Thrombosomes or CPP could circulate within the …See details»
Cellphire
Apr 2, 2021 About Cellphire. Cellphire, Inc. is a biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology …See details»